The Effect of Alpha Linolenic Acid (ALA) Supplementation During Pregnancy
Launched by SHEBA MEDICAL CENTER · Feb 1, 2017
Trial Information
Current as of August 28, 2025
Withdrawn
Keywords
ClinConnect Summary
DHA (Docosahexaenoic Acid ) is a long chain omega-3 fatty acid important for brain and eye development and function throughout life. It also supports heart health. DHA is the most abundant omega-3 in the brain and retina and is naturally found in breast milk. EPA (Eicosapentaenoic Acid ) is a long-chain omega-3 fatty acid important for overall health. However, unlike DHA, the body does not store EPA in significant quantities in the brain or retina (DHA is found in every cell throughout the body, EPA is not). These Omega 3 fatty acids are considered essential due to the inability of the huma...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-42
- • Singleton
- • Gestational age 12-16 during first visit at the high risk unit
- Exclusion Criteria:
- • Liver Disease
- • Dyslipidemia
- • Twins
- • Warfarin, LMWH, Heparin use ( Due to suspected drug interaction that has been reported however has not been proven yet)
About Sheba Medical Center
Sheba Medical Center, located in Israel, is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, Sheba Medical Center leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and developing novel therapeutic interventions. The center's collaborative environment fosters partnerships with global research organizations, enhancing its ability to contribute to the scientific community and drive medical advancements across various fields. With a strong focus on patient safety and ethical standards, Sheba Medical Center is dedicated to translating research findings into practical applications that benefit patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ramat Gan, , Israel
Patients applied
Trial Officials
Israel Hendler, M.D
Study Director
Department of Obstetrics and Gynecology ,Sheba Medical Center, Ramat Gan, Israel
Alicia Leikin-Frenkel, M.D, Ph.d
Study Director
Bert Strassburger Lipid Center, Sheba Medical Center, Ramat Gan, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials